Mechanism of Action and Pharmacokinetics
Chemically, Diclofenac-natrium is an acetic acid derivative (specifically, indoleacetic and phenylacetic acid derivatives). Within the classification of nonsteroidal anti-inflammatory drugs (NSAIDs), the drug functions as a reversible non-selective COX inhibitor, blocking both COX-1 and COX-2.
The core pharmacological mechanism involves the inhibition of prostaglandin synthesis, which mediate pain and inflammatory responses. A key pharmacokinetic feature of the drug is its excellent penetration into synovial cavities, directly determining its high efficacy in joint pathologies.
An important metabolic aspect is that diclofenac acts as an inhibitor of the CYP2C9 isoenzyme (along with sulfonamides and cimetidine), whereas ibuprofen, phenytoin, tolbutamide, and warfarin are substrates for this same isoenzyme.
Pharmacological Effects and Comparative Efficacy
The drug exhibits a potent combined profile, acting as both an anti-inflammatory and analgesic agent.
- Anti-inflammatory effect: More pronounced than that of indomethacin.
- Analgesic effect: Successfully relieves inflammatory pain associated with arthritis, myositis, and neuritis.
- Targeting: Due to its high tropism for musculoskeletal tissues, it is indispensable in rheumatological practice.
Clinical Indications
NSAIDs are prescribed for systemic and local therapy. Diclofenac-natrium is used in the following clinical scenarios:
- Chronic therapy: Ankylosing spondylitis, gout, chronic rheumatic diseases.
- Pain management: Acute postoperative pain relief.
- Ophthalmology: Administered as eye drops for topical treatment of ocular inflammatory conditions.
- Inflammatory processes: Arthritis, myositis, neuritis (leveraging its dual anti-inflammatory and analgesic properties).
Dosing Guidelines and Prescription Writing
Medical dosing relies on average therapeutic doses that yield the desired pharmacotherapeutic effect in the vast majority of patients. Due to individual sensitivity and condition severity, dosages are frequently expressed as a range.
- Formulations and dosages:
- Tablets: 0.025 g and 0.05 g.
- Injectable solution: 2.5% in 3 mL ampoules.
- Suppositories: 0.025 g, 0.05 g, and 0.1 g.
- Ointment: 1% (25 g).
- Routes of administration and dosing:
- Oral: 0.025–0.05 g 2–3 times daily. The maximum daily dose (MDD) is 0.150 g.
- Intramuscular: 0.005–0.02 g.
- Rectal: Once daily.
The concept of single dose (pro dosi) defines the quantity per administration, and daily dose (pro die) defines the total over 24 hours.